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Abstract
Background: Increased use of the transorbital approach (TOA) warrants greater understanding of the risk of
increased intraocular pressure (IOP) and intraorbital pressure (IORP) due to orbital compression. We aimed to
investigate the changes in IOP and IORP in response to orbital retraction in TOA and establish a method for the
continuous measurement of intraoperative IORP.
Methods: We assessed nine patients who underwent TOA surgery from January 2017 to December 2019, in
addition to five cadavers. IORP and IOP were measured using a cannula needle monitor, tonometer, cuff
manometer, and micro strain gauge monitor.
Results: In all nine clinical cases and five cadavers, increased physical compression of the orbit increased the IOP
and IORP in a curvilinear pattern. In clinical cases, when the orbit was compressed 1.5 cm from the lateral margin in
the sagittal plane, the mean IOP and IORP were 25.4 ± 5.2 mmHg and 14 ± 9.2 mmH2O, respectively. The IORP
satisfactorily reflected the IOP (Pearson correlation coefficient = 0.824, p < 0.001).
Conclusion: We measured IOP and IORP simultaneously during orbital compression to gain basic information on
pressure changes. In clinical cases, the change in the IOP could be conveniently and noninvasively monitored using
continuous IORP measurements.
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Background
Recent studies have focused on the transorbital approach
(TOA) as a minimally invasive approach for skull base le-
sions in the frontal and middle cranial fossa. TOA has sev-
eral advantages: lesser wounds, minimal brain retraction,
reduced cerebrospinal fluid (CSF) leakage, and shorter
and less time-consuming access to skull base lesions [1].
However, to date, the TOA has been applied in a lim-
ited number of clinical cases, and little is known about
its side effects. The possible ophthalmic complications
of TOA surgery include enophthalmos, epiphora, ptosis,
and diplopia [2]. In addition, many intraorbital compli-
cations may arise from direct injury during surgery. Sev-
eral factors, such as direct cranial nerve injury or
extraocular muscle injury due to surgery, may contribute
to ocular abnormalities [3]. These complications can also
occur when the intraocular pressure (IOP) and intraorbi-
tal pressure (IORP) increase due to the increased phys-
ical traction by retraction of the orbit and venous
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: jebeomhong@gmail.com
4Department of Neurosurgery, Kangbuk Samsung Hospital, Sungkyunkwan
University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 03181,
Korea
Full list of author information is available at the end of the article
Kim et al. BMC Ophthalmology           (2021) 21:76 
https://doi.org/10.1186/s12886-021-01834-5
pressure during surgery [4–7]. This can lead to visual
loss. When the IOP is either momentarily too high or
low, it may incur permanent damage to the optic nerve
or cause retinal detachment [8]. Therefore, testing the
IOP and IORP is critical in TOA surgical patients, and
their accurate measurement is essential.
The continuous measurement of IOP and IORP with a
retracted orbit remains challenging, despite several
measurement methods. We investigated the changes in
the IOP and IORP in TOA surgery. Furthermore, we
propose a useful measurement method for continuous
intraoperative IORP monitoring.
Methods
This prospective study included consecutive patients
who underwent transorbital endoscopic operations from
January 2017 to December 2019. Cadaver studies were
performed in the Surgical Neuroanatomy Laboratory.
The study was approved by the Institutional Review
Board and conducted in accordance with the ethical
guidelines of the Declaration of Helsinki. Written in-
formed consent was provided by all patients.
Cadaver studies
Five cadaveric specimens (10 eyeballs) without eye dam-
age, including orbital disease, periorbital disease, and
head trauma, were examined. Cadavers with enophthal-
mos due to premortem or postmortem dehydration were
excluded. Cadaveric specimens were processed based on
previously described methods [9]. The retractor blade
was withdrawn from 0.0 to 2.5 cm in 0.5 cm increments
for orbital retraction from the orbital rim to the coronal
plane. The average values of three IOP and IORP mea-
surements were obtained.
IOP was measured by a handheld tonometer (Tono-
Pen AVIA® Handheld Tonometer, Reichert Inc., USA)
and direct cannulation to the eyeball using a Philips
IntelliVue MP30 monitor (Philips Medical Systems,
Eindhoven, The Netherlands).
This cannulation method consisted of the insertion of
a 26-gauge needle into the anterior chamber through the
limbus (superomedial position) of each eye [10, 11]. The
cannulation was performed based on manufacturer’s in-
structions and as previously described [12].
The Tono-Pen AVIA® was used very carefully, without
applying any orbital pressure, and calibrated according
to the manufacturer’s manual. The IOP was effectively
measured once a right-angle contact with the corneal
surface was established. The average value was recorded
three times.
The IORP was measured using a cuff manometer
(Cufflator, JT Posey Company, Arcadia, CA, USA) and a
3-mm tracheal tube by placing a pressure measuring cuff
on the tracheal tube between the retractor blade and the
periorbit.
Clinical cases
The inclusion criteria were as follows: (1) TOA surgery
to treat intracranial pathology, (2) written informed con-
sent from the patient, and (3) no CSF leakage prior to
IOP and IORP measurements. The exclusion criteria
were as follows: (1) preoperative visual field defect and
visual acuity less than 0.05, (2) IOP greater than 20
mmHg preoperatively, and (3) any ophthalmological dis-
ease, particularly glaucoma. All patients were tested for
IOP, visual acuity, and visual field before and after sur-
gery by the ophthalmologist.
After induction of general anesthesia and intubation,
the patient was positioned in an intraoperative supine
state with the reverse Trendelenburg at 30 degrees. An
oculoplastic surgeon performed the TOA protocol, as
per previous cadaver studies [9]. An ophthalmologist
measured the IOP at the beginning of the surgery. Pres-
sure measurements were taken at 10-min intervals. A
skilled inspector of each measuring instrument, blinded
to the results of other tools, measured the parameters.
IOP and IORP were individually measured according
to the degree of orbital retraction during surgery. During
orbital retraction from the orbital rim to the coronal
plane, the retractor blade (DORO® Blades for DORO
LUNA® Retractor System) was withdrawn from 0.0 to
2.5 cm in 0.5-cm increments, and an average value was
obtained after measuring the IOP and IORP three times.
The iCare pro (iCare Finland Oy, Helsinki, Finland)
tonometer was used to measure the IOP. Similar to the
cadaver studies, the average of three final measurements
was acquired (Fig. 1a).
A micro strain gauge monitor system (CODMAN MI-
CROSENSOR Transducer & CODMAN® MICROSEN-
SOR® Basic Kit, Codman, Raynham, MA, USA) was used
for measuring IORP in clinical cases based on the manu-
facturer’s instructions (Fig. 1b). The distal catheter tip was
placed between the periorbit and the retraction blade.
Statistical analysis
A paired Student’s t-test was used for the statistical ana-
lysis of IOP and IORP changes. A Pearson correlation
coefficient was calculated with a linear regression model
to assess the correlation between IOP and IORP. SPSS
version 22.0 (Statistical Package for Social Sciences,
SPSS Inc., Chicago, IL, USA) was employed for statistical
analyses, with a significance level set to p < 0.05.
Results
Cadaver studies
The mean IOP ± SD values measured by Tono-Pen
AVIA® at every 0.5-cm retraction, from 0.0 to 2.5 cm,
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were 4.9 ± 5.78, 8.2 ± 6.92, 17.2 ± 9.59, 24.1 ± 12.08,
34.1 ± 10.32, and 41.9 ± 9.04 mmHg. A greater degree of
retraction increased the IOP proportionately (Fig. 2a).
The IOP, as measured by the cannula needle, was set
to 0 mmHg prior to orbital retraction. The mean IOP ±
SD values measured by the cannula pressure monitoring
method were 0.0, 6.6 ± 3.72, 12.8 ± 6.58, 19.5 ± 10.75,
32.9 ± 32.00, and 54.6 ± 40.49 mmHg at each retraction
(Fig. 2b).
The mean IORP±SD values measured by the cuff man-
ometer were 8.5 ± 2.55, 10.1 ± 2.33, 12.4 ± 3.44, 15.3 ±
4.19, 24.4 ± 9.44, and 35.2 ± 12.99 cmH2O, when the
orbit was retracted from 0.0 to 2.5 cm at an interval of
0.5 cm (Fig. 2c).
Patient characteristics
The demographic data of clinical subjects and their IOP
are presented in Table 1. Of the nine patients, one was
male. The mean age was 44.5 ± 14.3 years (range, 23–70
years). The pathological findings included schwannomas
(n = 5), meningiomas (n = 3), and glioma (n = 1). The
sites of the tumor differed, but all were accessible via
TOA surgery. The mean tumor size (±SD, range) was
26.6 mm (±7.4, 20–41.7, maximum diameter). The mean
preoperative and postoperative IOP values (±SD, range)
were 13.2 mmHg (±1.7, 11–16) and 13.0 mmHg (±1.3,
11–14) on the left side, and 13.3 mmHg (±1.9, 11–16)
and 14.3 mmHg (±2.6, 11–19) on the right side, respect-
ively. There was no difference in visual acuity or visual
field before and after the operation.
IOP and IORP in clinical cases
The initial mean value of intraoperative IOP of the
tumor side measured by iCare was 12.7 ± 2.33 mmHg.
The mean IOP values consecutively measured by in-
creasing the distance of the retraction blade from 0.0 to
2.0 cm, at an interval of 0.5 cm from the lateral orbital
wall, were 12.7 mmHg (±2.3, 8–15), 15.8 mmHg (±1.8,
13.5–18.6), 21.1 mmHg (±4.5, 15.8–28), 25.4 mmHg (±
5.2, 18.9–34), and 46.6 mmHg (±8.8, 38.5–64.2), forming
a curvilinear pattern (Fig. 3a). The IORP was continu-
ously measured using a micro strain gauge monitor,
increasing the retraction by 0.5 cm from 0.0 to 2.0 cm.
The mean IORP values were 0.0 mmHg, 3.5 mmHg (±
2.9, 1–10), 7.8 mmHg (±5.7, 3–21), 14 mmHg (±9.2, 6–
35), and 24.8 mmHg (±15.6, 13–62). As the retraction
Fig. 1 Pressure measurement in clinical cases. a IOP measurement by iCare pro tonometer. b IORP measurement by micro strain gauge monitor.
IOP-intraocular pressure; IORP- intraorbital pressure
Fig. 2 Pressure measurement in cadaveric study. a IOP measured by Tono-Pen AVIA®. b IOP measured by cannula needle monitor. c IORP
measured by manometer. ns = not significant; *p < 0.01; **p < 0.001. IOP-intraocular pressure; IORP- intraorbital pressure
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increased, the IORP also increased in a curvilinear pat-
tern (Fig. 3b). The pressure increased gradually when
the retraction was less than 1.5 cm, but increased
abruptly when the retraction was greater than 1.5 cm.
Finally, the mean IOP and IORP values increased to
46.6 mmHg from 12.7 mmHg and to 24.8 mmHg from
0.0 mmHg, respectively, when the orbit was compressed
to 2.0 cm. In a linear regression analysis of the differ-
ences between IOP and IORP, there was a significant
correlation between IOP and IORP (Pearson correlation
coefficient = 0.824, p < 0.001) (Fig. 4).
Discussion
Risk of increased IOP and IORP
The IOP indicates a dynamic balance between the for-
mation and outflow of aqueous humor [13]. The mean
IOP is approximately 14–16 mmHg (±3.5 mmHg during
a 24-h cycle) in the general population, and an IOP be-
tween 7 and 21mmHg is considered normal [13–15].
A normal IORP ranges from 3 to 6 mmHg [16, 17]. A
rapid increase in IORP is associated with orbital
structural damage causing irreversible vision loss [18].
The proposed mechanism underlying this ophthalmo-
logic complication is a rapid increase in IORP within
the rigid confines of the orbit, resulting in hypoperfu-
sion of critical neural structures. This is defined as
orbital compartment syndrome (OCS). In OCS, optic
nerve and retinal damage may develop into rapidly ir-
reversible vision loss.
An elevated IOP due to orbit retraction during TOA
surgery might lower the eye perfusion pressure, leading
to perioperative visual loss (POVL). High IOP is still the
most important risk factor linked to an untreated glau-
comatous eye (> 21mmHg) progressing to a severe
stage. Glaucoma is characterized by optic nerve atrophy
and impaired vision, and is the main cause of increased
IOP causing neuropathy [19–22].
There are no reports of OCS complications in the
application of TOA, even if these are likely to occur. Al-
though no serious adverse events such as temporary or
permanent POVL or visual disturbance due to an in-
crease in IOP during surgery are reported in TOA
Table 1 Patient data in clinical cases





Preop. IOP Postop. IOP
Lt Rt Lt Rt
1 F 39 Schwannoma V2, PPF, Lt. 12.5 × 23.4 × 24.4 Supine, neutral 14 16 14 19
2 F 42 Schwannoma Trigeminal, Lt. 21 × 18.8 × 23.2 Supine, neutral 16 15 14 16
3 F 42 Meningioma CS wall, Lt. 31.1 × 32.6 × 35.2 Supine, neutral 15 12 11 12
4 F 42 Meningioma Temporal tip, Lt. 17.5 × 20.3 × 19.5 Supine, neutral 11 14 12 13
5 F 47 Schwannoma Trigeminal, Rt. 30 × 21.4 × 24.9 Supine, neutral 12 11 13 13
6 F 35 Schwannoma Trigeminal, Rt 41.7 × 31.5 × 27.3 Supine, neutral 11 12 11 13
7 F 70 Meningioma ACP, Lt. 28 × 19.1 × 22.2 Supine, neutral 14 15 14 17
8 M 58 Schwannoma CS, Rt. 25.1 × 23 × 22.4 Supine, neutral 13 14 14 15
9 F 23 Glioma Temporal tip 20.3 × 21.2 × 18.6 Supine, neutral 13 11 14 11
ACP anterior clinoid process, CS cavernous sinus, F female, IOP intraocular pressure, Lt left; M male, Postop. postoperative, PPF pterygopalatine fossa, Preop.
preoperative, Rt right
Fig. 3 Pressure measurement in clinical cases. a IOP measured by tonometry. b IORP measured by micro strain gauge manometer. ns = not
significant; *p < 0.01; **p < 0.001. IOP-intraocular pressure; IORP- intraorbital pressure
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surgery, neurosurgeons should be aware and cautious of
the risks.
IOP and IORP measurements
Currently, the most accurate clinical tonometer is the
Goldmann applanation tonometer (GAT). When meas-
uring IOP, iCare yields high values compared to the
GAT, but the results are similar enough for iCare to be
used as an alternative when it is difficult to use the GAT
due to its high correlation [23]. In this study’s clinical
cases, the GAT was replaced with iCare for its ease of
measuring the intraoperative IOP.
In the past, the slit catheter technique, direct orbital
manometry, and orbitonometer methods were used for
measuring IORP [16, 17, 24]. In this study, we used a
micro strain gauge as a less invasive method and found
it to be useful.
Surgical considerations
An increased orbital pressure for over 60–100 min can
cause permanent visual complications [18, 25]. Although
there may be differences depending on the applied pres-
sure, position, and contact area, the mean recovery time
of IOP was reported to be 22.3 ± 2.2 min when a 15-g
weight was applied for 1 min [26]. Therefore, it is neces-
sary to consciously relieve the pressure on the orbit dur-
ing TOA surgery. We collected basic information on the
possible retraction range that would not cause complica-
tions during TOA surgery.
We intended to validate an instrument for measuring
IOP and IORP and quantify pressure increments due to
external ocular compression during TOA surgery. Our
results showed that as the orbit was retracted, IOP and
IORP increased in a curvilinear pattern (Fig. 3). In the
cadaver study, we found that both IOP and IORP
increased rapidly when pulled over 2 cm on inspection
using a cuff manometer and a cannula needle monitor-
ing system (Fig. 2). The slope of the ascending curve of
iCare measurements showed a gradual increase in IOP
when retracting the orbit to less than 1.5 cm, and an
abrupt rise above 1.5 cm. Furthermore, when the orbit
was compressed to 2.0 cm during TOA surgery, the
mean IOP was 46.6 ± 8.8 mmHg, with the highest value
being 64.2 mmHg (range, 38.5–64.2 mmHg).
The preferred method for measuring IOP is iCare to-
nometry through direct contact with the cornea. If mea-
sured during TOA surgery, it is impossible to detect an
increased IOP induced by the excessive traction of the
orbit continuously. However, IORP could be measured
continuously using a micro strain gauge monitor system.
In addition, IORP measured using a micro strain gauge
shows a high correlation with IOP measured using the
iCare tonometer (Fig. 4). This IORP measurement
method could be useful in compensating for the short-
comings of the tonometer.
Limitations
There are some limitations to this study. First, only a
small number of patients who had a normal IOP were
investigated. Second, we did not consider the geometry
of the retractor and contact surface. Third, since the mi-
cro gauge catheter tip has a very small contact area, the
IORP may not be accurately reflected based on the pos-
ition of the catheter tip. Finally, we did not consider
changes in IOP due to delayed surgical time, damage of
the periorbita, or CSF leakage, and did not compare the
blood pressure or the reverse Trendelenburg level at the
time of IOP measurement. We are in the process of data
collection, and these limitations will be addressed in fu-
ture studies.
Conclusions
We measured IOP and IORP simultaneously in cadaver
and clinical cases of transorbital surgery. The IOP and
IORP increase in a curvilinear pattern when the orbit is
retracted. Retracting the orbit medially to more than 1.5
cm from the lateral orbital wall may increase IOP to a
critical level. The change in IOP can be conveniently
and noninvasively monitored using continuous IORP
measurements.
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